Benchmark Reiterates Buy Rating on Immunoprecise Antibodies Ltd. (IPA)

January 23, 2025 2:35 PM EST Send to a Friend
Benchmark analyst Robert Wasserman reiterated a Buy rating and $3.00 price target on Immunoprecise Antibodies Ltd. (NASDAQ: IPA).The analyst said ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login